Insiders Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Delayed Japan Exchange Other stock markets 11:30:00 31/05/2024 am IST			5-day change	1st Jan Change
4,173 ^JPY	+1.88%		+0.94%	+2.94%

02/06	GSK blood cancer drug nearly halves risk of death in late-stage trial	RE
31/05	Takeda Pharmaceutical Says Recombinant ADAMTS13 Gets Approval Recommendation From European Medicines Agency's CHPM	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon	09/05	CI
Takeda Pharmaceutical Names Milano Furuta as Chief Financial Officer	01/02	MT
Top Stories at Midday: Chicago PMI Shifts Back to Contraction; Alibaba Loses JD.com Antitrust Case; BuzzFeed President to Resign; Pfizer, Other Drugmakers Plan Price Increases; Boeing Says China 737 Max Jets Back in Service	29/12	MT
Antisense Therapeutics Appoints CEO/Managing Director	07/23/07	MT
Takeda Pharmaceutical Company Limited Announces Board Changes	28/23/28	CI
Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th	30/23/30	CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO	29/23/29	AN
Takeda Named Global Top Employer for Sixth Consecutive Year	17/23/17	BU
Takeda Pharmaceutical Company Limited Announces New Assignments of Directors	29/22/29	CI
Takeda Pharmaceutical Company Limited Announces Board Appointments	29/22/29	CI
OncoSec Medical Names Robert Arch CEO; Shares Rise Early	30/22/30	MT
Takeda Pharmaceutical Company Limited Announces Executive Changes	01/22/01	CI
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium	22/22/22	RE
Takeda Announces Management Changes	03/22/03	CI
Takeda Named Global Top Employer for Fifth Consecutive Year	20/22/20	BU
Takeda Announces New Assignments of Directors	29/21/29	CI
Takeda Pharmaceutical Company Limited Announces Retirement of Yasuhiko Yamanaka as Director and Member of Audit and Supervisory Committee	28/21/28	CI
Takeda Announces Directorate Changes	31/21/31	CI
Takeda Pharmaceutical Company Limited Announces Executive Changes	15/21/15	CI
Nabriva Therapeutics : Names Daniel Dolan CFO	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Insiders

Filters